FBTAX vs. FBIOX
Compare and contrast key facts about Fidelity Advisor Biotechnology Fund Class A (FBTAX) and Fidelity Select Biotechnology Portfolio (FBIOX).
FBTAX is managed by Fidelity. It was launched on Dec 27, 2000. FBIOX is managed by Fidelity. It was launched on Dec 16, 1985.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FBTAX or FBIOX.
Key characteristics
FBTAX | FBIOX | |
---|---|---|
YTD Return | 4.79% | 3.54% |
1Y Return | 17.13% | 11.66% |
3Y Return (Ann) | 3.81% | -2.39% |
5Y Return (Ann) | 10.73% | 7.83% |
10Y Return (Ann) | 8.83% | 7.70% |
Sharpe Ratio | 0.95 | 0.58 |
Daily Std Dev | 18.63% | 20.83% |
Max Drawdown | -60.08% | -71.96% |
Current Drawdown | -8.99% | -23.59% |
Correlation
The correlation between FBTAX and FBIOX is 0.98, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
FBTAX vs. FBIOX - Performance Comparison
In the year-to-date period, FBTAX achieves a 4.79% return, which is significantly higher than FBIOX's 3.54% return. Over the past 10 years, FBTAX has outperformed FBIOX with an annualized return of 8.83%, while FBIOX has yielded a comparatively lower 7.70% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBTAX vs. FBIOX - Expense Ratio Comparison
FBTAX has a 1.00% expense ratio, which is higher than FBIOX's 0.69% expense ratio.
Risk-Adjusted Performance
FBTAX vs. FBIOX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class A (FBTAX) and Fidelity Select Biotechnology Portfolio (FBIOX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FBTAX vs. FBIOX - Dividend Comparison
FBTAX's dividend yield for the trailing twelve months is around 1.10%, more than FBIOX's 0.78% yield.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fidelity Advisor Biotechnology Fund Class A | 1.10% | 1.15% | 0.00% | 20.12% | 8.37% | 6.77% | 2.50% | 0.00% | 0.00% | 5.36% | 2.45% | 0.28% |
Fidelity Select Biotechnology Portfolio | 0.78% | 0.45% | 0.00% | 14.48% | 19.46% | 8.89% | 11.18% | 1.41% | 3.42% | 6.71% | 10.77% | 0.25% |
Drawdowns
FBTAX vs. FBIOX - Drawdown Comparison
The maximum FBTAX drawdown since its inception was -60.08%, smaller than the maximum FBIOX drawdown of -71.96%. Use the drawdown chart below to compare losses from any high point for FBTAX and FBIOX. For additional features, visit the drawdowns tool.
Volatility
FBTAX vs. FBIOX - Volatility Comparison
The current volatility for Fidelity Advisor Biotechnology Fund Class A (FBTAX) is 4.44%, while Fidelity Select Biotechnology Portfolio (FBIOX) has a volatility of 5.03%. This indicates that FBTAX experiences smaller price fluctuations and is considered to be less risky than FBIOX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.